Systematically exploring repurposing effects of antihypertensives.

Area of Science:

• Pharmacology and Pharmacoepidemiology
• Computational Biology and Bioinformatics
• Biostatistics and Epidemiology

Background:

• Observational data, including electronic health records and claims data, are increasingly available for drug repurposing research.
• Screening for drug repurposing opportunities requires robust methodologies to infer causal effects from non-randomized data.
• Antihypertensive drugs are widely prescribed, presenting a large pool of candidates for repurposing.

Purpose of the Study:

• To comprehensively explore the repurposing effects of antihypertensive drugs on a wide range of health outcomes.
• To apply a target trial emulation framework for causal inference to observational data.
• To identify novel therapeutic applications for existing antihypertensive medications.

Main Methods:

• Utilized a linked database of insurance claims and electronic health records.
• Emulated randomized controlled trials using target trial emulation to estimate confounding-adjusted effects.
• Assessed the effects of antihypertensives on 262 distinct health outcomes.
• Applied hierarchical models for postprocessing to manage multiple comparisons and refine findings.

Main Results:

• The study identified potential drug repurposing opportunities for antihypertensive medications across various outcomes.
• The target trial emulation framework provided adjusted effect estimates for antihypertensives on numerous health conditions.
• Hierarchical modeling helped in systematically sifting through results and accounting for multiple testing.

Conclusions:

• This empirical approach demonstrates the feasibility of using large observational datasets for drug repurposing.
• The findings highlight specific antihypertensive drugs with potential benefits for nonindicated outcomes.
• The study provides insights into methodological considerations and potential biases in real-world drug repurposing research.